Name

EOX

Alternate names

None

Primary Site

None

Histology

None

Radiation

None

Remarks

None

Drugs for EOX

Name

Alternate Names

4'-Epiadriamycin Hydrochloride
4'-Epidoxorubicin
4-EA
Ellence
Epidoxorubicin
Epidoxorubicin Hydrochloride
Epirubicin Hydrochloride
IMI-28
Pharmorubicin
Pidorubicin Hydrochloride

Abbreviations

EPI
epi-ADR

Category

Chemotherapy

Subcategory

Anthracycline
Antitumor antibiotic

NSC Number

256942

Primary Site

Breast cancer
Metastatic breast cancer
Gastric cancer

Histology

None

Remarks

Coding

This drug should be coded

Name

Alternate Names

1-OHP
1670 RBl Eloxatin
Eloxatin
L-OHP
Oxalatoplatin
Oxalatoplatinum
PR-54780
RP-54780
Transplatin

Abbreviations

None

Category

Chemotherapy

Subcategory

Platinum analog

NSC Number

266046

Primary Site

Colorectal
gastro-esophageal cancers, metastatic
liver
ovarian
pancreatic cancer

Histology

None

Remarks

A platinum-containing antineoplastic that is usually given in combiantion with 5-FU.

Coding

This drug should be coded

Name

Alternate Names

Ro 091978
Ro-09-1978
Ro-091978
Xeloda

Abbreviations

None

Category

Chemotherapy

Subcategory

Antimetabolite

NSC Number

712807

Primary Site

Breast cancer
colorectal cancer

Histology

None

Remarks

FDA approved for colorectal cancer Capecitabine is an oral prodrug of both doxifluridine and 5-fluorouracil. FDA approved use in breast and colorectal cancers. Hoffman LaRoche.

Coding

This drug should be coded
Glossary